Search

Displaying results 6251 - 6260 of 9324 in total
  1. Drug

    Zevotrelvir

    go.drugbank.com/drugs/DB21638
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor. Zevotrelvir has a monoisotopic molecular weight of 537.2 Da.

  2. Drug

    Limnetrelvir

    go.drugbank.com/drugs/DB21677
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Limnetrelvir is a antiviral 3CL protease inhibitor. Limnetrelvir has a monoisotopic molecular weight of 557.17 Da.

  3. Drug

    Orenasitecan

    go.drugbank.com/drugs/DB21718
    Experimental

    The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor. Orenasitecan has a monoisotopic molecular weight of 1470.58 Da.

  4. Drug

    Epsametostat

    go.drugbank.com/drugs/DB21726
    Experimental

    The usage of the INN stem '-metostat' in the name indicates that Epsametostat is a histone N-methyltransferase inhibitor. Epsametostat has a monoisotopic molecular weight of 611.28 Da.

  5. Drug

    Mocaciclib

    go.drugbank.com/drugs/DB21730
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor. Mocaciclib has a monoisotopic molecular weight of 609.3 Da.

  6. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).

  7. Drug

    Flurocitabine

    go.drugbank.com/drugs/DB20317
    Experimental

    The usage of the INN stem '-citabine' in the name indicates that Flurocitabine is a nucleoside antiviral or antineoplastic agent, cytarabine or azacitidine derivative.

  8. Drug

    Edotecarin

    go.drugbank.com/drugs/DB04882
    Investigational

    It is member of the class of compounds called indolocarbazoles.

  9. Drug

    NCX 1015

    go.drugbank.com/drugs/DB05825
    Experimental

    NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory bowel disease (IBD) by NicOx SA.

  10. Drug

    ROX-888

    go.drugbank.com/drugs/DB05364
    Experimental

    ROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.